Trial
NCT01507545
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Morphotek
Collaborators
—
Condition
Metastatic Colorectal Cancer
Intervention
MORAb-004
Why stopped
By the sponsor at the end of Stage 1 due to futility.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-05-06